Dr. Alex Slandzicki, MD
Claim this profileClinical Trials Center of Middle TN
Studies Coronavirus
Studies COVID-19
3 reported clinical trials
6 drugs studied
Area of expertise
1Coronavirus
SARS-CoV-2
PCR
collection
2COVID-19
SARS-CoV-2
Affiliated Hospitals
More about Alex Slandzicki, MD
Clinical Trial Related1 year of experience running clinical trials · Led 3 trials as a Principal Investigator · 0 Active Clinical TrialsTreatments Alex Slandzicki, MD has experience with
- Montelukast
- Placebo
- Ivermectin
- Fluvoxamine
- Fluticasone
- Metformin
Breakdown of trials Alex Slandzicki, MD has run
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alex Slandzicki, MD specialize in?
Alex Slandzicki, MD focuses on Coronavirus and COVID-19. In particular, much of their work with Coronavirus has involved SARS-CoV-2 patients, or patients who are PCR.
Is Alex Slandzicki, MD currently recruiting for clinical trials?
No, Alex Slandzicki, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Alex Slandzicki, MD has studied deeply?
Yes, Alex Slandzicki, MD has studied treatments such as Montelukast, Placebo, Ivermectin.
What is the best way to schedule an appointment with Alex Slandzicki, MD?
Apply for one of the trials that Alex Slandzicki, MD is conducting.
What is the office address of Alex Slandzicki, MD?
The office of Alex Slandzicki, MD is located at: Clinical Trials Center of Middle TN, Franklin, Tennessee 37067 United States. This is the address for their practice at the Clinical Trials Center of Middle TN.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.